MarketFriction

Aspira Pathlab & Diagnostics Ltd

BSE 540788 · Healthcare Service Provider
₹131.25 -4.74%
BSE close2026-10-01
Market cap₹148 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3.323.463.824.646.185.415.785.258.095.126.526.17
Expenses3.683.833.954.294.834.654.734.445.906.336.855.83
Operating Profit-0.36-0.37-0.130.351.350.761.050.812.19-1.21-0.330.34
OPM %-10.84%-10.69%-3.40%7.54%21.84%14.05%18.17%15.43%27.07%-23.63%-5.06%5.51%
Other Income0.140.100.080.090.080.090.130.110.140.130.140.12
Interest0.100.090.080.080.080.090.090.090.100.100.100.09
Depreciation0.390.380.380.380.360.390.370.370.400.380.400.41
Profit before tax-0.71-0.74-0.51-0.020.990.370.720.461.83-1.56-0.69-0.04
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-0.71-0.74-0.50-0.020.990.380.720.471.84-1.56-0.69-0.04
EPS in Rs-0.69-0.72-0.49-0.020.960.370.700.461.79-1.52-0.67-0.04
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales0.000.764.367.648.4215.2119.5414.4613.2022.0024.9825.90
Expenses0.233.348.2410.8810.2511.6913.1612.8614.3818.4423.5224.91
Operating Profit-0.23-2.58-3.88-3.24-1.833.526.381.60-1.183.561.460.99
OPM %-339.47%-88.99%-42.41%-21.73%23.14%32.65%11.07%-8.94%16.18%5.84%3.82%
Other Income0.320.310.220.250.290.200.090.320.420.360.520.53
Interest0.050.260.800.961.010.890.370.420.370.350.390.39
Depreciation0.000.201.121.231.661.441.641.591.541.491.541.59
Profit before tax0.04-2.73-5.58-5.18-4.211.394.46-0.09-2.672.080.05-0.46
Tax %25.00%0.00%0.00%0.00%0.71%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit0.03-2.72-5.58-5.18-4.241.384.46-0.09-2.672.070.05-0.45
EPS in Rs0.13-5.24-10.75-6.32-4.561.344.33-0.09-2.592.010.05-0.44
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%10%20%15%
Compounded Profit Growth5%-49%37%-118%
Stock Price CAGR%14%59%131%
Return on Equity%11%-3%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital2.252.255.195.198.199.2910.2910.2910.2910.2910.2910.29
Reserves1.361.390.72-4.86-7.93-10.42-6.91-2.43-2.47-5.08-3.01-2.99
Borrowings0.002.627.2911.3612.5213.807.018.858.247.718.138.25
Other Liabilities0.210.031.660.842.021.671.391.421.281.792.112.95
Total Liabilities3.826.2914.8612.5314.8014.3411.7818.1317.3414.7117.5218.50
Fixed Assets0.000.047.797.918.908.707.759.578.016.796.537.20
CWIP0.000.000.250.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.130.00
Other Assets3.826.256.824.625.905.644.038.569.337.9210.8611.30
Total Assets3.826.2914.8612.5314.8014.3411.7818.1317.3414.7117.5218.50
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-0.37-1.29-4.81-3.39-1.875.672.03-0.011.051.881.45
Cash from Investing Activity-0.02-10.14-0.77-1.970.24-0.09-0.510.160.140.07-0.80
Cash from Financing Activity2.648.916.523.351.27-2.17-1.35-0.94-0.95-0.99-1.14
Net Cash Flow2.25-2.520.94-2.00-0.353.410.17-0.790.240.95-0.49
Free Cash Flow-0.41-8.41-5.81-3.90-1.925.371.42-0.150.791.710.75
CFO/OP139%50%124%105%101%161%32%-1%-89%53%99%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days43.2229.3038.2226.0140.8083.8759.0761.9438.9925.28
Inventory Days312.86103.8845.2251.3651.3546.5058.4062.6950.3156.53
Days Payable730.0064.5846.8473.3791.6070.9151.10101.7073.0092.06
Cash Conversion Cycle-373.9268.6136.604.000.5559.4666.3722.9316.30-10.25
Working Capital Days-2,199.61-5.86-96.03-127.0116.3269.3048.7225.1614.10-2.92
ROCE %1.82%-25.39%-38.41%-34.49%-25.15%19.77%35.65%2.01%-15.87%17.37%2.84%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters18.90%18.90%18.72%18.72%18.55%18.55%18.39%18.39%18.39%18.39%18.39%46.58%
Public81.10%81.10%81.29%81.28%81.46%81.46%81.62%81.62%81.61%81.61%81.61%53.41%
No. of Shareholders1,4061,3511,5121,6951,7061,5931,7411,7701,7551,7841,7691,620

Fundamentals

Market Cap₹ 148 Cr.
Current Price₹ 143
Book Value₹ 7.09
ROCE2.84 %
ROE0.69 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)15%
Compounded Profit Growth (TTM)-118%
Standalone figures.
Valuation
Market capRs 135 Cr
Enterprise valueRs 142 Cr
Price to book18.51x
Price to sales5.22x
EV / EBITDA93.20x
EV / sales5.47x
Price to cash flow93.17x
Earnings yield-0.33%
P/E, 3-year average596.05x
P/B, 3-year average8.68x
P/E, 5-year average402.35x
P/B, 5-year average7.64x
Profitability
Operating margin (excl. other income)5.84%
Operating margin (incl. other income)7.93%
EBITDA margin5.87%
Pre-tax margin-1.78%
Net profit margin-1.74%
Net margin, latest quarter-0.65%
ROE0.69%
ROCE2.84%
ROA0.28%
ROE, 3-year average-2.38%
ROCE, 3-year average1.37%
ROA, 3-year average-1.18%
ROE, 5-year average14.21%
ROCE, 5-year average8.36%
ROA, 5-year average5.16%
ROIC (approx.)-0.50%
Other income / net worth7.12%
Growth
Sales growth (latest year)13.55%
Profit growth (latest year)-97.58%
Sales CAGR, 3 years19.99%
Sales CAGR, 5 years10.43%
Profit CAGR, 5 years-48.50%
Sales growth QoQ-5.37%
Sales growth YoY (latest quarter)17.52%
Profit growth YoY (latest quarter)-108.51%
Per share
EPS (TTM)Rs -0.44
EPS (latest year)Rs 0.05
EPS (latest quarter)Rs -0.04
EPS, 3-year averageRs -0.18
EPS, 5-year averageRs 0.74
Book value per shareRs 7.09
Sales per shareRs 25.16
Cash flow per shareRs 1.41
Free cash flow per shareRs 0.73
Efficiency
Asset turnover1.35x
Fixed asset turnover3.47x
Inventory turnover10.84x
Inventory days34 days
Debtor days25 days
Debtors turnover14.44x
Creditor days92 days
Cash conversion cycle-10 days
Working capital days-3 days
Leverage
Total debtRs 8 Cr
Cash and bankRs 2 Cr
Net debtRs 7 Cr
Debt to equity1.13x
Net debt / EBITDA4.32x
Interest coverage-0.18x
Owners' fund to total sources39.46%
Debt to assets44.59%
Cash flow
Cash from Operating Activity (latest year)Rs 1 Cr
Cash from Investing Activity (latest year)Rs -1 Cr
Cash from Financing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 1 Cr
Cash from ops / profit, 5 years1.68x
Sales to cash flow17.23x
Statement figures
Net sales (TTM)Rs 26 Cr
Net sales (latest year)Rs 25 Cr
Sales (latest quarter)Rs 6 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 2 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 2 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 8 Cr
Total expenditure (latest year)Rs 24 Cr
Total income (latest year)Rs 26 Cr
Share capitalRs 10 Cr
ReservesRs -3 Cr
Shareholders' fundsRs 7 Cr
Total assetsRs 18 Cr
Net blockRs 7 Cr
ReceivablesRs 2 Cr
InventoryRs 1 Cr
Other liabilitiesRs 3 Cr
Shares outstanding (crore)1.03
Ownership
Promoter holding46.58% (+28.19 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 18.51 is at the 78th percentile (median 8.97).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period540788Nifty 50Difference
1 week+1.0%-2.8% +3.8 pts
1 month+46.2%-6.8% +53.0 pts
3 months+1.0%-7.6% +8.6 pts
3 years+270.2%+14.2% +256.1 pts
5 years+78.8%+27.9% +50.9 pts

Red flags

F-score 6 of 8
explainLow interest cover Interest cover 1.1x in 2026
lookProfit leans on other income Other income was 1040% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹6 Cr +17.5% vs Jun 2025. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Choksi Laboratories Ltd13269.29.44 %
Star Imaging and Path Lab Ltd1316.8026.1 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Aspira Pathlab & Diagnostics Ltd?

Aspira Pathlab & Diagnostics Ltd (540788) has a market capitalisation of Rs 148 Cr. at the 2026-10-01 close.

What were Aspira Pathlab & Diagnostics Ltd's latest quarterly results?

In the Jun 2026 quarter, Aspira Pathlab & Diagnostics Ltd sales was Rs 6 Cr (+17.5% vs Jun 2025) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03